2019/01/04 Reven News Press

Reven Hires Susan Moore. Susan Moore hired as Reven’s Senior Director of Regulatory and Clinical Affairs.

2019/01/08 Reven News Press

MAD Cohort 3 begins seven-day dosing period.

2018/12/19 Reven News Press

Reven Hires Natalie Pizzimenti. Natalie Pizzimenti hired as Reven’s Clinical Research Scientist.

2018/12/18 Reven News Press

MAD Cohort 2 completed dosing on December 18, 2018.

2018/12/11 Reven News Press

MAD Cohort 2 begins seven-day dosing period.

2018/12/05 Reven News Press

SAD Cohort 6C doses subjects; SAD Cohort 6 is completed.

2018/12/03 Reven News Press

Reven Hires Crysta Huszai. Crysta Huszai hired as Reven’s Quality Specialist.

2018/11/30 Reven News Press

SAD Cohort 6b dosing completed.

2018/11/27 Reven News Press

SAD Cohort 6 Underway. SAD Cohort 6A doses subjects.

2018/11/19 Reven News Press

MAD Cohort 1 Completed.

2018/11/13 Reven News Press

MAD Cohort 1 Begins. MAD Cohort 1 begins seven-day dosing period.

2018/10/26 Reven News Press

SAD Cohort 5 Completed. SAD Cohort 5B doses subjects; Cohort 5 has finished.

2018/10/25 Reven News Press

SAD Cohort 5 Underway. SAD Cohort 5A doses subjects.

2018/10/05 Reven News Press

SAD Cohort 4 doses subjects; Cohort 4 has finished.

2018/09/21 Reven News Press

Marissa Mazzolini hired as Reven’s Medical Affairs Manager.